We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical
BMY (bristol myers squibb)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
191 24 0 BMY
Emcee:  trevor john wilkinson Type:  Unmoderated
Anybody any comments

Zacks rating 2
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
191I exited BMY because I did not want to hold bag for CELG SH. First, let them exiMiljenko Zuanic-June 25
190BMY investor sentiment has become unduly bearish, IMO. I didn’t want the CELG meDewDiligence_on_SI-June 24
189<Remicade-type blockbuster> It is not revlimid type blockbuster, unless thMiljenko Zuanic-June 24
188With that forced divestiture news alone, nearly all of the 8 1/2% gain I'd sThehammer-June 24
187BMY can still get reasonable value for Otezla. They don't have to accept theDewDiligence_on_SI-June 24
186Fuck. I bought BMY just because of Celgene's Otezla, which is shaping up tozax-June 24
185Otezla for sale, Why Otezla? And who? And, for how much? 4-5X Miljenko Zuanic-June 24
184The Eliquis CoM patent has already been extended, so I think the answer is no.DewDiligence_on_SI1April 26
183<Eliquis is a monster. Too bad it goes off-patent in 2026.> Is there any Miljenko Zuanic-April 25
182You should check out Celgene's pipeline. Otezla is shaping up to be a monstzax-April 25
181twitter.comDewDiligence_on_SI-April 25
180Eliquis is a monster. Too bad it goes off-patent in 2026.DewDiligence_on_SI-April 25
179Bristol-Myers Squibb Company (BMY) 45.64 + 1.02 (+2.29%) I'm in as of 4/22 zax-April 25
178Message 32005281Miljenko Zuanic-January 31
177How can they believe in anything when landscape changes overnight? Even Tom sounMiljenko Zuanic-January 24
176Hard to tell whether BMY executives honestly believe what they are telling invesDewDiligence_on_SI-January 24
175AI approach may be proper answer when implementing bio-marker analysis before caMiljenko Zuanic-January 24
1744Q CC..... some significant deterioration of the scientific rating scale at BMY;Miljenko Zuanic-January 24
173From other board: Subject 24574 < Message 31960602 > MF guy is lost in hiMiljenko Zuanic-January 6
172NICE continue to be key benchmark in assessing drug cost-effectiveness. Who willMiljenko Zuanic-11/30/2018
171In a maintenance setting, it's pretty hard to beat a placebo, crazy as that DewDiligence_on_SI-11/26/2018
170Yes, but it was *placebo* they have to bit! Pathetic! :-( So, maintenance = IGNMiljenko Zuanic-11/26/2018
169In many kinds of cancer, the first-line maintenance setting is a difficult placeDewDiligence_on_SI-11/26/2018
168It is rely going on my nerve, right now! CM-451 failed OS! Zuanic-11/26/2018
167To me, looks like it is going nowhere, until CM227 is out! By that time, God HEMiljenko Zuanic-11/21/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):